The US Food and Drug Administration has approved Crinecerfont for treatment of classic congenital adrenal hyperplasia, ...

Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...

Adrenal cancer is very rare ... If you decide to join one, you will see the same physicians and nurses as you would for standard therapy. Your care team will talk with you about if you might want to ...

The concept of a tapering schedule for chronic corticosteroid therapy evolved to prevent adrenal insufficiency syndrome and recurrence or exacerbation of signs and symptom. Patients are more ...

Recognized as innovative biopharma developing a potentially safer and superior anticoagulant for patients with implanted cardiac devices and rare cardiovascular conditions PONTE VEDRA, Fla.

Adrenal gland diseases are disorders characterized by hyperfunction or hypofunction of the adrenal glands, resulting in either high levels or low levels of the hormones produced by the adrenal ...

Orthostatic hypotension is a key distinguisher between presentations of steroid-induced adrenal insufficiency and HIV-related lipodystrophy. In patients taking cobicistat-containing antiretroviral ...

"Cadrenal Therapeutics has demonstrated a commitment to filling a serious gap in anticoagulation therapy," said Lisa Winget, Managing Editor at Pharma Tech Outlook. "We are pleased to recognize ...

Nov. 19, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, has been ...